Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1998-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/JCEM.83.2.4584PMID 9467535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endogenous overnight creatinine clearance, serum beta 2-microglobulin and serum water during the menstrual cycle.

  2009cited by this paper
• Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study.

  1997cited by this paper
• Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women.

  1996cited by this paper
• Bone turnover markers and bone density across the menopausal transition.

  1996cited by this paper
• Measurement of Bone-Specific Alkaline Phosphatase by an Immunoselective Enzyme Assay Method

  1996cited by this paper
• Cytokine production in the bone marrow microenvironment: failure to demonstrate estrogen regulation in early postmenopausal women.

  1996cited by this paper
• Urinary N‐Telopeptides to Monitor Bone Resorption While on GnRH Agonist Therapy

  1996cited by this paper
• Calcium-regulating hormones across the menstrual cycle: evidence of a secondary hyperparathyroidism in women with PMS.

  1995cited by this paper
• Urinary biochemical markers for bone resorption during the menstrual cycle

  1995cited by this paper
• The effects of gonadotrophin-releasing hormone agonists on iliac crest cancellous bone structure in women with endometriosis.

  1995cited by this paper
• The Short-Term Effects of Conjugated Estrogen on Bone Turnover in Older Women

  1995cited by this paper
• Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement.

  1995cited by this paper
• The short-term effects of conjugated estrogen on bone turnover in older women.

  1994cited by this paper
• Direct, enzyme‐linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption

  1994cited by this paper
• Immunoassay for quantifying type I collagen degradation products in urine evaluated.

  1994cited by this paper
• Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.

  1994cited by this paper
• Possible variation in bone resorption during the normal menstrual cycle.

  1993cited by this paper
• Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation.

  1993cited by this paper
• Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.

  1993cited by this paper
• Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry

  1993cited by this paper
• Modified immunoradiometric assay of parathyroid hormone-related protein: clinical application in the differential diagnosis of hypercalcemia.

  1992cited by this paper
• Sandwich immunoassay for intact human osteocalcin.

  1992cited by this paper
• Measurement of serum osteocalcin with a human‐specific two‐site immunoradiometric assay

  1992influential reference
• Increased osteoclast development after estrogen loss: mediation by interleukin-6.

  1992cited by this paper
• The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones.

  1991cited by this paper
• Effects of a combined estrogen‐gestagen regimen on serum levels of the carboxy‐terminal propeptide of human type I procollagen in osteoporosis

  1991cited by this paper
• Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells.

  1991cited by this paper
• Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.

  1990cited by this paper
• Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors

  1990cited by this paper
• Changes in biochemical markers of osteoblastic activity during the menstrual cycle.

  1990influential reference
• Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.

  1989cited by this paper
• Evidence of estrogen receptors in normal human osteoblast-like cells

  1988cited by this paper
• The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism.

  1988cited by this paper
• Enhanced osteoblast proliferation and collagen gene expression by estradiol.

  1988cited by this paper
• Evidence of estrogen receptors in normal human osteoblast-like cells.

  1988cited by this paper
• Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.

  1988cited by this paper
• Procollagen type I carboxy‐terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase

  1987cited by this paper
• Interaction between parathyroid hormone and endogenous estrogen in normal women.

  1986cited by this paper
• Calcium-regulating hormones across the menstrual cycle.

  1986cited by this paper
• Unchanged biochemical indices of bone turnover despite fluctuations in 1,25-dihydroxyvitamin D during the menstrual cycle.

  1983cited by this paper
• Fluctuation of serum concentration of 1,25-dihydroxyvitamin D3 during the menstrual cycle.

  1982cited by this paper
• SERIAL CHANGES IN 24 HOUR CREATININE CLEARANCE DURING NORMAL MENSTRUAL CYCLES AND THE FIRST TRIMESTER OF PREGNANCY

  1981cited by this paper
• Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma.

  1980cited by this paper
• Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.

  1980cited by this paper
• Effect of the menstrual cycle on calcium-regulating hormones in the normal young woman.

  1980cited by this paper
• Postmenopausal and senile osteoporosis: current concepts of etiology and treatment.

  1979cited by this paper
• Calcium-regulating hormones during the menstrual cycle.

  1978cited by this paper
• Glucocorticoid receptors and inhibition of bone cell growth in primary culture.

  1977cited by this paper
• Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease.

  1975cited by this paper
• Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis.

  1972cited by this paper
• Alkaline-phosphatase activity during menstruation.

  1968cited by this paper

• Understanding Bone Metabolism Biomarker Variability Across the Menstrual Cycle: A Systematic Review

  2026cites this paper
• The effects of menstrual cycle phases on immune function and inflammation at rest and after acute exercise: A systematic review and meta‐analysis

  2023cites this paper
• Menstrual Cycle Related Fluctuations in Circulating Markers of Bone Metabolism at Rest and in Response to Running in Eumenorrheic Females

  2022cites this paper
• Sex Differences in Biological Systems and the Conundrum of Menopause: Potential Commonalities in Post-Menopausal Disease Mechanisms

  2022cites this paper
• Bone Turnover Markers: Basic Biology to Clinical Applications

  2022cites this paper
• Influence of short-term ovarian stimulation on bone metabolism in women undergoing fertility treatment

  2021cites this paper
• Plasma Interleukin-10 Levels Are Altered in Women with Severe Premenstrual Syndrome: A Preliminary Study

  2020cites this paper
• Regulation of Bone Mass and Body Composition by Anterior Pituitary Hormones

  2020cites this paper
• Emerging concepts in the epidemiology, pathophysiology, and clinical care of osteoporosis across the menopausal transition.

  2018cites this paper
• The Effect of Sex Hormones on Ligament Structure, Joint Stability and ACL Injury Risk

  2017cites this paper
• Changes of serum sclerostin and Dickkopf-1 levels during the menstrual cycle. A pilot study

  2016cites this paper
• The effects of energy availability on bone metabolism and health

  2016cites this paper
• Evaluation of menstrual cycle-related changes in 85 clinical laboratory analytes

  2016cites this paper
• C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression.

  2014cites this paper
• Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women.

  2014cites this paper
• Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle

  2013cites this paper
• Changes in serum collagen markers, IGF‐I, and Knee joint laxity across the menstrual cycle

  2012cites this paper
• Blood biochemical markers of bone turnover: pre-analytical and technical aspects of sample collection and handling

  2012cites this paper
• Mathematische Modellierung der Knochenremodellierung

  2012cites this paper
• A Change of Osteocalcin (OC) and Tartrate Resistant Acid Phosphatase 5b (TRACP-5b) with the Menstrual Cycle

  2012cites this paper
• Preanalytical Variables and Biological Variation

  2012cites this paper
• Adiponectin and bone metabolism markers in female rowers: Eumenorrheic and oral contraceptive users

  2010cites this paper
• The Efficacy of Hypericum perforatum (St John’s Wort) for the Treatment of Premenstrual Syndrome

  2010cites this paper
• Progesterone and Bone: Actions Promoting Bone Health in Women

  2010cites this paper
• A new approach to accelerate orthodontic tooth movement in women: Orthodontic force application after ovulation.

  2010cites this paper
• New and Emerging Therapies for Osteoporosis

  2010influential citation
• Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United States

  2009cites this paper
• Establishing a reference range for bone turnover markers in young, healthy women.

  2008cites this paper
• Role of calcium metabolism in premenstrual syndrome

  2008cites this paper
• Rapid suppression of bone resorption marker levels with ibandronate therapy in a bisphosphonate-naïve population.

  2008cites this paper
• Bone turnover marker profile in relation to the menstrual cycle of premenopausal healthy women

  2008influential citation
• Lower insulin-like growth factor-1 concentrations in women with premenstrual dysphoric disorder.

  2008cites this paper
• EFFECT OF ACUTE RESISTANCE EXERCISE ON BONE METABOLISM DURING MENSTRUAL CYCLE

  2007cites this paper
• Impact of Gender and Menstrual Cycle Phase on Plasma Cytokine Concentrations

  2007cites this paper
• Short-term prolactin administration causes expressible galactorrhea but does not affect bone turnover: pilot data for a new lactation agent

  2007cites this paper
• Modeling of Serum C‐Telopeptide Levels with Daily and Monthly Oral Ibandronate in Humans

  2006cites this paper
• Eating restraint is negatively associated with biomarkers of bone turnover but not measurements of bone mineral density in young women.

  2006cites this paper
• Abstracts for the American Association of Clinical Endocrinologists 15th Annual Meeting and Clinical Congress, April 26-30, 2006, Chicago, Illinois, USA.

  2006cites this paper
• Relationship between stages of the estrous cycle and bone cell activity in Thoroughbreds.

  2006cites this paper
• Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women.

  2005cites this paper
• Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance.

  2005cites this paper
• A randomized placebo-controlled trial of short-term graded transdermal estradiol in healthy gonadotropin-releasing hormone agonist-suppressed pre- and postmenopausal women: effects on serum markers of bone turnover, insulin-like growth factor-I, and osteoclastogenic mediators.

  2005cites this paper
• [Relationship of deoxypyridinole excretion with bone density, serum estradiol and years of postmenopause in Mexican postmenopausic women].

  2004cites this paper
• Fibrous Dysplasia: Changes During the Menstrual Cycle and in Response to Zoledronate

  2004cites this paper
• Does the estrogenic phase modify the bone and mineral metabolism response in rats under hyperthyroidism

  2003cites this paper
• Bone Mineral Density and Biomarkers of Bone Turnover in Young-Adult Females with and without Cognitive Eating Restraint

  2003cites this paper
• Estrous-cycle-dependent Variation in Orthodontic Tooth Movement

  2002cites this paper
• The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases.

  2002cites this paper
• Chapter 90 – Biochemical Markers of Bone Metabolism

  2002cites this paper
• Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinoline.

  2002cites this paper
• Periodische Änderungen der Knochenremodellierung

  2001influential citation
• Phasic production of urinary pyridinium crosslinks in mice: The effect of ovariectomy

  2001cites this paper
• Variability in urinary excretion of bone resorption markers: limitations of a single determination in clinical practice.

  2001cites this paper
• Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women.

  2000cites this paper
• Preanalytical Variability of Biochemical Markers of Bone Turnover

  2000cites this paper
• Ovariectomy does not induce osteopenia through interleukin-6 in rhesus monkeys (Macaca mulatta).

  2000cites this paper
• Changes in biochemical bone markers during pregnancy and puerperium.

  2000cites this paper
• Physiologic fluctuations of serum estradiol levels influence biochemical markers of bone resorption in young women.

  2000cites this paper
• Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women.

  2000cites this paper
• Measurement of Cytokines in Clinical Samples Using Immunoassays: Problems and Pitfalls

  2000cites this paper
• Growth Hormone (GH) Effects on Bone and Collagen Turnover in Healthy Adults and Its Potential as a Marker of GH Abuse in Sports: A Double Blind, Placebo-Controlled Study

  2000cites this paper
• Modulation of IL-6 production during the menstrual cycle in vivo and in vitro.

  2000cites this paper
• Changes in Bone Turnover During the Menstrual Cycle in Cynomolgus Monkeys

  2000influential citation
• Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group.

  2000cites this paper
• Correlation of estradiol, parathyroid hormone, interleukin-6, and soluble interleukin-6 receptor during the normal menstrual cycle.

  2000cites this paper
• Effects of progestins on bone: an update.

  1999cites this paper
• Characterization of the progestin receptors in the human TE85 and murine MC3T3-E1 osteoblast-like cell lines.

  1999cites this paper
• Oestrogens prevent the increase of human serum soluble interleukin‐6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro

  1999cites this paper
• A collection method and high-sensitivity enzyme immunoassay for sweat pyridinoline and deoxypyridinoline cross-links.

  1999cites this paper
• CHAPTER 41 – Estrogen

  1999cites this paper
• Biochemical markers of bone turnover.

  1999cites this paper
• Premenstrual syndromes: closing the 20th century chapters.

  1999cites this paper
• Changes in Bone Resorption During the Menstrual Cycle

  1999influential citation
• Circulating biochemical markers of bone remodeling in uremic patients.

  1999cites this paper